Term: Angiotensin Converting Enzyme (ACE) Inhibitor Use
Last Updated: 2006-02-15
The percentage of residents who received at least one prescription for ACE Inhibitors (ATC codes C09A, C09B) in 2003/04. The primary use of ACE inhibitors is to lower blood pressure. Values are adjusted to reflect the total population of Manitoba (males and females combined).
- Anatomical Therapeutic Chemical (ATC) Drug Classification System
- Angiotensin Converting Enzyme Inhibitors (ACEIs)
- Angiotensin II Receptor Blockers (ARB)
- Fransoo R, Martens P, The Need to Know Team, Burland E, Prior H, Burchill C, Chateau D, Walld R. Sex Differences in Health Status, Health Care Use, and Quality of Care: A Population-Based Analysis for Manitoba's Regional Health Authorities. Winnipeg, MB: Manitoba Centre for Health Policy, 2005. [Report] [Summary] [Additional Materials] (View)
Manitoba Centre for Health Policy
Community Health Sciences, Max Rady College of Medicine,
Rady Faculty of Health Sciences,
Room 408-727 McDermot Ave.
University of Manitoba
Winnipeg, MB R3E 3P5 Canada